Screen the A10 antibody for off-target binding to plasma membrane proteins and secreted proteins

Location: Federal
Posted: Feb 6, 2026
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Type of Contract: Awards
Type of Government: Federal
Category:
  • 66 - Instruments and Laboratory Equipment
Solicitation No: 75N91026P00004
Publication URL: To access bid details, please log in.
Follow
Screen the A10 antibody for off-target binding to plasma membrane proteins and secreted proteins
Active
Contract Opportunity
Notice ID
75N91026P00004
Related Notice
Contract Line Item Number
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
OFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION (ASA)
Office
PROGRAM SUPPORT CENTER ACQ MGMT SVC
Award Details
  • Contract Award Date: Jan 27, 2026
  • Contract Award Number: 75N91026P00004
  • Task/Delivery Order Number:
  • Contractor Awarded Unique Entity ID: KWY4CPWDFNT6
  • Contractor Awarded Name: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
  • Contractor Awarded Address: Saffron Walden CB10 1XL GBR
  • Base and All Options Value (Total Contract Value): $38,750.00
General Information
  • Contract Opportunity Type: Award Notice (Original)
  • Original Published Date: Feb 06, 2026 10:02 am EST
  • Inactive Policy: 15 days after contract award date
  • Original Inactive Date: Feb 11, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside: No Set aside used
  • Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
  • NAICS Code:
    • 541380 - Testing Laboratories and Services
  • Place of Performance:
    Saffron , GB-ESS
    GBR
Description

This is a Firm Fixed Priced purchase order. NCI solicited and negotiated directly with Charles River Discovery Research Services UK Limited. The National Cancer Institute (NCI) has a program to use an antibody called, 'A10' to target cancer cells that have a lot of the epidermal growth factor receptor on their cell surface. While this antibody has been extensively tested and characterized it is not known if it also binds any other cell surface proteins. The contractor shall perform an off-target screen on an NCI antibody and report back on any problematic interactions that could predict a serious side effect should the antibody be given to a cancer patient. The A10 is NOT known to bind other cell surface proteins or secreted proteins but this needs to be addressed in the off-target screen.


Attachments/Links
Contact Information
Contracting Office Address
  • 12501 ARDENNES AVE. SUITE 400
  • ROCKVILLE , MD 20857
  • USA
Primary Point of Contact
Secondary Point of Contact


History
  • Feb 06, 2026 10:02 am ESTAward Notice (Original)
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

...Follow CNC Plasma Arc Cutting Machine Active Contract Opportunity Notice ID W911KF26QA037 Related... ...

DEPT OF DEFENSE

Bid Due: 6/10/2026

...Follow TECHNOLOGY TRANSFER LICENSING OPPORTUNITY: Plasma Processing of Water and Inedible Biomass...: Researchers ...

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

Bid Due: 7/17/2026

...analysis in plasma samples Attachments/Links Contact Information Contracting Office Address 6011...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 6/07/2026

...-based untargeted omics tools to identify blood metabolites, circulating plasma proteins, and global...

VETERANS AFFAIRS, DEPARTMENT OF

Bid Due: 6/05/2026

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.